National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No.3)
Instrument number PB 30 of 2012
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 23 May 2012
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
1 Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No.3).
(2) This Determination may also be cited as PB 30 of 2012.
This Determination commences on 1 June 2012.
3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
 Schedule 2, after item dealing with Amlodipine
Amlodipine with Atorvastatin
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.